Cargando…
Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy—Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance
SIMPLE SUMMARY: While the definition of the prostate bed clinical target volume (CTV) has been proposed in consensus guidelines, various PTV expansions have been proposed. Depending on the institution, isotropic or non-isotropic expansions on the prostate bed CTV may be considered. This is a prelimi...
Autores principales: | Laughlin, Brady S., Yu, Nathan Y., Lo, Stephanie, Duan, Jingwei, Welchel, Zachary, Tinnon, Katie, Beckett, Mason, Schild, Steven E., Wong, William W., Keole, Sameer R., Rwigema, Jean-Claude M., Vargas, Carlos E., Rong, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817842/ https://www.ncbi.nlm.nih.gov/pubmed/36612040 http://dx.doi.org/10.3390/cancers15010040 |
Ejemplares similares
-
Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy—Part 1: Consistent Organs at Risk Management with Advanced Image Guidance
por: Laughlin, Brady S., et al.
Publicado: (2022) -
Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience
por: Laughlin, Brady S., et al.
Publicado: (2022) -
Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost
por: Laughlin, Brady S., et al.
Publicado: (2022) -
Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy
por: Laughlin, Brady S., et al.
Publicado: (2022) -
Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003
por: Laughlin, Brady S., et al.
Publicado: (2022)